This is not to be viewed as a trade; it is to be viewed as a long-term hold.
Sentiment: Strong Buy
Absolutely! If Celldex gets 2 approvals in 2016 that would be unheard of for a small biotech. Of course, I would not mind if one of the 2 lead drugs got approved in 2015.
I FULLY agree....this is a long term winner.
Sniping aside, this Management is slow and steady with their eyes on the balls.
I own over 20,000 shares and have not traded one share....and a good thing I have not I would have missed many trades the way its moving. Holding till a buy out within 1 -3 years.